SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-22-022706
Filing Date
2022-06-07
Accepted
2022-06-07 17:09:13
Documents
6
Effectiveness Date
2022-06-07

Document Format Files

Seq Description Document Type Size
1 S-8 apvo-s8.htm S-8 82817
2 EX-5.1 apvo-ex51_59.htm EX-5.1 10300
3 EX-23.1 apvo-ex231_100.htm EX-23.1 2917
4 EXHIBIT_107 apvo-exfilingfees_42.htm EX-FILING FEES 52284
5 GRAPHIC gfxrnw3ggcmr000001.jpg GRAPHIC 752
6 GRAPHIC g1jrudsvwcl3000001.jpg GRAPHIC 25554
  Complete submission text file 0001564590-22-022706.txt   185857
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265468 | Film No.: 221001889
SIC: 2834 Pharmaceutical Preparations